
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.71 | 3.71 | 0.00 |
Shares | 96.29 | 96.29 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 22.06 | 22.09 |
Price to Book | 2.79 | 3.14 |
Price to Sales | 2.11 | 2.11 |
Price to Cash Flow | 14.11 | 12.37 |
Dividend Yield | 0.50 | 0.65 |
5 Years Earnings Growth | 11.15 | 14.19 |
Name | Net % | Category Average |
---|---|---|
Technology | 38.91 | 23.94 |
Healthcare | 21.05 | 20.24 |
Industrials | 18.51 | 20.32 |
Consumer Cyclical | 9.21 | 11.09 |
Financial Services | 6.02 | 10.12 |
Consumer Defensive | 5.29 | 4.59 |
Real Estate | 1.00 | 2.92 |
Number of long holdings: 68
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Prestige Consumer Health | US74112D1019 | 2.87 | 76.50 | -1.34% | |
RB Global | CA74935Q1072 | 2.47 | 108.16 | +0.44% | |
Q2 Holdings | US74736L1098 | 2.41 | 89.19 | -3.67% | |
ExlServices | US3020811044 | 2.38 | 42.29 | -6.31% | |
Descartes Systems | CA2499061083 | 2.25 | 138.29 | -3.04% | |
Dorman | US2582781009 | 2.25 | 122.50 | -2.15% | |
Cohen Steers | US19247A1007 | 2.23 | 76.77 | -1.04% | |
Globus Medical | US3795772082 | 2.10 | 57.12 | -1.18% | |
Cyberark Software | IL0011334468 | 1.98 | 374.80 | -0.42% | |
AptarGroup | US0383361039 | 1.97 | 157.90 | -0.27% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Nicholas | 4.19B | 2.81 | 18.81 | 10.92 | ||
Nicholas II I | 1B | 1.71 | 10.71 | 9.13 | ||
Nicholas Equity Income I | 465.4M | 4.69 | 10.00 | 8.85 | ||
Nicholas II N | 74.02M | 6.45 | 1.33 | 9.34 | ||
Nicholas Limited Edition N | 17.02M | 11.58 | -0.25 | 9.01 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review